Advertisement

Index by author

December 01, 2019; Volume 96,Issue 6

A

  1. Adlere, Ilze

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  2. Andersen, Signe

    1. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657

  3. Arimont, Marta

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
    3. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

B

  1. Bachelerie, Françoise

    1. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

  2. Baek, Yi-Yong

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  3. Baker, Jillian G.

    1. Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515

  4. Balabanian, Karl

    1. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

  5. Barrella, Lorenzo

    1. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

  6. Biggin, Philip C.

    1. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

  7. Bobkov, Vladimir

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  8. Briddon, Stephen

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  9. Briddon, Stephen J.

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  10. Bünemann, Moritz

    1. Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515

C

  1. Calhoun, Jacob

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  2. Capoferri, Davide

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  3. Caspar, Birgit

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
    2. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    3. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  4. Chavez-Abiega, Sergei

    1. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

  5. Chen, Gang

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

  6. Chen, Lijuan

    1. The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

  7. Choi, Seunghwan

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

D

  1. de Esch, Iwan

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  2. de Graaf, Chris

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  3. De Groof, Timo W.M.

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  4. de Haard, Hans

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  5. Dekkers, Sebastian

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  6. Durroux, Thierry

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

F

  1. Fumagalli, Amos

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

G

  1. Gallego, Carmen

    1. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

H

  1. Ha, Kwon-Soo

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  2. Heasley, Lynn E.

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  3. Heuninck, Joyce

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  4. Hill, Stephen

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  5. Hill, Stephen J.

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
    2. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360

  6. Hinz, Trista K.

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  7. Hoffmann, Carsten

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477
    2. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168

  8. Hunt, Martina S.

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

I

  1. Işbilir, Ali

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

J

  1. Jackson, William F.

    1. Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822

  2. Jeoung, Dooil

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

K

  1. Kellam, Barrie

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  2. Kim, Ji-Yoon

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  3. Kim, Jihye

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  4. Kim, Joohwan

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  5. Kim, Suji

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  6. Kim, Taesam

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  7. Kim, Young-Myeong

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  8. Kleczko, Emily K.

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  9. Koenen, Joyce

    1. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

  10. Kolb, Peter

    1. Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515

  11. Kristensen, Anders S.

    1. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657
    2. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

  12. Kunselman, Jennifer M.

    1. Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267

  13. Kwon, Young-Guen

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

L

  1. Ladefoged, Lucy Kate

    1. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657

  2. Lazarus, Philip

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

  3. Lee, Hansoo

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  4. Leurs, Rob

    1. Open Access
      Chemokine Receptor Crystal Structures: What Can Be Learned from Them?
      Marta Arimont, Carsten Hoffmann, Chris de Graaf and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 765-777; DOI: https://doi.org/10.1124/mol.119.117168
    2. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  5. Li, Yong

    1. The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

  6. Lohse, Martin J.

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

M

  1. Marek, Lindsay A.

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  2. Marin, Philippe

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

  3. Mayor, Federico

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

  4. Milligan, Graeme

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  5. Mohammadi, Mohammadjavad

    1. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176

  6. Munro, Lachlan

    1. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657

  7. Musgaard, Maria

    1. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

N

  1. Neubig, Richard R.

    1. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176
    2. Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822

  2. Neves, Maria

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

  3. Niu, Lu

    1. The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

P

  1. Padmanathan, Vithushan

    1. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657

  2. Park, Minsik

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  3. Park, Wonjin

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

  4. Perpiñá Viciano, Cristina

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  5. Phan, Hoa T.N.

    1. Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822

  6. Pin, Jean-Philippe

    1. Open Access
      Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
      Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, Birgit Caspar, Davide Capoferri, Stephen J. Briddon, Thierry Durroux, Stephen J. Hill, Martin J. Lohse, Graeme Milligan, Jean-Philippe Pin and Carsten Hoffmann
      Molecular Pharmacology December 2019, 96 (6) 778-793; DOI: https://doi.org/10.1124/mol.118.115477

  7. Puthenveedu, Manojkumar A.

    1. Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267

Q

  1. Quinn, Josiah A.

    1. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176

S

  1. Scharf, Magdalena M.

    1. Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
      Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker and Peter Kolb
      Molecular Pharmacology December 2019, 96 (6) 851-861; DOI: https://doi.org/10.1124/mol.119.117515

  2. Schiøtt, Birgit

    1. Conformational Changes in the 5-HT3A Receptor Extracellular Domain Measured by Voltage-Clamp Fluorometry
      Lachlan Munro, Lucy Kate Ladefoged, Vithushan Padmanathan, Signe Andersen, Birgit Schiøtt and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 720-734; DOI: https://doi.org/10.1124/mol.119.116657

  3. Schlecht-Louf, Géraldine

    1. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
      Joyce Koenen, Françoise Bachelerie, Karl Balabanian, Géraldine Schlecht-Louf and Carmen Gallego
      Molecular Pharmacology December 2019, 96 (6) 809-818; DOI: https://doi.org/10.1124/mol.118.115329

  4. Shaw, Vincent S.

    1. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176
    2. Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822

  5. Shi, Jian

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

  6. Singleton, Katherine R.

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  7. Smit, Martine J.

    1. From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function
      Martine J. Smit and Jacqueline E. van Muijlwijk-Koezen
      Molecular Pharmacology December 2019, 96 (6) 735-736; DOI: https://doi.org/10.1124/mol.119.118364
    2. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    3. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
    4. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

  8. Stenum-Berg, Charlotte

    1. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

  9. Stocks, Michael

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  10. Stuijt, Jeffrey

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  11. Sutliff, Aimee K.

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

T

  1. Tan, Aik Choon

    1. Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines
      Trista K. Hinz, Emily K. Kleczko, Katherine R. Singleton, Jacob Calhoun, Lindsay A. Marek, Jihye Kim, Aik Choon Tan and Lynn E. Heasley
      Molecular Pharmacology December 2019, 96 (6) 862-870; DOI: https://doi.org/10.1124/mol.119.117804

  2. Thisted, Christine L.

    1. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors
      Charlotte Stenum-Berg, Maria Musgaard, Sergei Chavez-Abiega, Christine L. Thisted, Lorenzo Barrella, Philip C. Biggin and Anders S. Kristensen
      Molecular Pharmacology December 2019, 96 (6) 835-850; DOI: https://doi.org/10.1124/mol.119.116871

V

  1. van den Bor, Jelle

    1. The Role of ACKR3 in Breast, Lung, and Brain Cancer
      The Role of ACKR3 in Breast, Lung, and Brain Cancer
      Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor
      Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279

  2. van der Woning, Bas

    1. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  3. van Muijlwijk-Koezen, Jacqueline E.

    1. From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function
      Martine J. Smit and Jacqueline E. van Muijlwijk-Koezen
      Molecular Pharmacology December 2019, 96 (6) 735-736; DOI: https://doi.org/10.1124/mol.119.118364

  4. Vashisth, Harish

    1. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19
      Vincent S. Shaw, Mohammadjavad Mohammadi, Josiah A. Quinn, Harish Vashisth and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 683-691; DOI: https://doi.org/10.1124/mol.119.117176

  5. Visser, Kirsten

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

W

  1. Watson, Christy J.W.

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881

  2. Watts, Stephanie W.

    1. Loss-of-Function Mutations in Human Regulator of G Protein Signaling RGS2 Differentially Regulate Pharmacological Reactivity of Resistance Vasculature
      Hoa T.N. Phan, William F. Jackson, Vincent S. Shaw, Stephanie W. Watts and Richard R. Neubig
      Molecular Pharmacology December 2019, 96 (6) 826-834; DOI: https://doi.org/10.1124/mol.119.116822

  3. Weinberg, Zara Y.

    1. Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267

  4. Wijtmans, Maikel

    1. Open Access
      Modulators of CXCR4 and CXCR7/ACKR3 Function
      Ilze Adlere, Birgit Caspar, Marta Arimont, Sebastian Dekkers, Kirsten Visser, Jeffrey Stuijt, Chris de Graaf, Michael Stocks, Barrie Kellam, Stephen Briddon, Maikel Wijtmans, Iwan de Esch, Stephen Hill and Rob Leurs
      Molecular Pharmacology December 2019, 96 (6) 737-752; DOI: https://doi.org/10.1124/mol.119.117663

  5. Won, Moo-Ho

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

Y

  1. Yan, Wei

    1. The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

  2. Yang, Jianhong

    1. The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

  3. Ye, Haoyu

    1. The Natural Compound Withaferin A Covalently Binds to Cys239 of β-Tubulin to Promote Tubulin Degradation
      Jianhong Yang, Wei Yan, Yong Li, Lu Niu, Haoyu Ye and Lijuan Chen
      Molecular Pharmacology December 2019, 96 (6) 711-719; DOI: https://doi.org/10.1124/mol.119.117812

  4. Yun, Jung-A

    1. Open Access
      N-Terminal Modification of the Tetrapeptide Arg-Leu-Tyr-Glu, a Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Antagonist, Improves Antitumor Activity by Increasing its Stability against Serum Peptidases
      Jung-A Yun, Joohwan Kim, Yi-Yong Baek, Wonjin Park, Minsik Park, Suji Kim, Taesam Kim, Seunghwan Choi, Dooil Jeoung, Hansoo Lee, Moo-Ho Won, Ji-Yoon Kim, Kwon-Soo Ha, Young-Guen Kwon and Young-Myeong Kim
      Molecular Pharmacology December 2019, 96 (6) 692-701; DOI: https://doi.org/10.1124/mol.119.117234

Z

  1. Zajac, Amanda S.

    1. Homologous Regulation of Mu Opioid Receptor Recycling by Gβγ, Protein Kinase C, and Receptor Phosphorylation
      Jennifer M. Kunselman, Amanda S. Zajac, Zara Y. Weinberg and Manojkumar A. Puthenveedu
      Molecular Pharmacology December 2019, 96 (6) 702-710; DOI: https://doi.org/10.1124/mol.119.117267

  2. Zarca, Aurélien

    1. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Open Access
      CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
      Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin
      Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
    2. Open Access
      Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
      Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
      Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

  3. Zhu, Hao-Jie

    1. Open Access
      Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver
      Aimee K. Sutliff, Jian Shi, Christy J.W. Watson, Martina S. Hunt, Gang Chen, Hao-Jie Zhu and Philip Lazarus
      Molecular Pharmacology December 2019, 96 (6) 674-682; DOI: https://doi.org/10.1124/mol.119.115881
Back to top

In this issue

Advertisement